By Sheena Cruickshank, University of Manchester and Jonathan Worboys, for The ConversationA new immunotherapy drug has demonstrated early promise in a recent prostate cancer clinical trial. The drug, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results